A mind-altering medication chemically akin to ketamine will be made cheaper to improve the lives of Australians suffering from treatment-resistant depression - the first new government-backed initiative to treat the chronic mental illness in decades.
The drug - which comes in the form of a nasal spray - is a chemical cousin of ketamine, used for decades as a powerful anaesthetic before it was adopted as a party drug in underground rave culture.
